Stay updated on Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial

Sign up to get notified when there's something new on the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now identifies the website as revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T15:49:25.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH's terminology transition from “Artificial Intelligence” to “Super Intelligence” and directs users to updates and FAQs.
    Difference
    0.5%
    Check dated 2026-10-25T15:48:23.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.1 to v3.7.2. The study information remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-18T16:12:01.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T16:40:38.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 entry is added to the record history. The previous Revision: v3.6.6 is removed, updating the page’s version-history display to reflect the latest platform release.
    Difference
    0.1%
    Check dated 2026-09-20T19:56:15.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page's record history shows Revision: v3.6.6 instead of v3.6.5, indicating a software/UI revision in the history metadata. This change is metadata and does not alter trial data or the content of the study record.
    Difference
    0.1%
    Check dated 2026-08-30T15:17:55.000Z thumbnail image

Stay in the know with updates to Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page.